Journal
TRENDS IN MICROBIOLOGY
Volume 23, Issue 4, Pages 185-191Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.tim.2015.01.006
Keywords
bacteriophages; phage therapy; genetic modification; recombineering
Categories
Funding
- FCT [PEst-OE/EQB/LA0023/2013, SFRH/BD/86462/2012]
- Project 'BioHealth - Biotechnology and Bioengineering approaches to improve health quality' [NORTE-07-0124-FEDER-000027]
- Programa Operacional Regional do Norte (ON.2 - O Novo Norte)
- QREN
- FEDER
- Fundação para a Ciência e a Tecnologia [SFRH/BD/86462/2012] Funding Source: FCT
Ask authors/readers for more resources
The success of phage therapy is dependent on the development of strategies able to overcome the limitations of bacteriophages as therapeutic agents, the creation of an adequate regulatory framework, the implementation of safety protocols, and acceptance by the general public. Many approaches have been proposed to circumvent phages' intrinsic limitations but none have proved to be completely satisfactory. In this review we present the major hurdles of phage therapy and the solutions proposed to circumvent them. A thorough discussion of the advantages and drawbacks of these solutions is provided and special attention is given to the genetic modification of phages as an achievable strategy to shape bacteriophages to exhibit desirable biological properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available